デフォルト表紙
市場調査レポート
商品コード
1751078

産後うつ病治療の世界市場レポート 2025年

Postpartum Depression Treatment Global Market Report 2025


出版日
ページ情報
英文 175 Pages
納期
2~10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.35円
産後うつ病治療の世界市場レポート 2025年
出版日: 2025年06月17日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

産後うつ病治療市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.4%で17億米ドルに成長します。予測期間中の成長は、新規即効性治療法の開発、デジタルメンタルヘルスソリューションの採用拡大、メンタルヘルスサービスに対する保険適用の拡大、個別化治療アプローチに対する需要の高まり、ホルモン療法への注目の高まりなどに起因すると考えられます。予測期間に予想される主な動向には、神経ステロイドベースの療法の出現、産後ケアにおける遠隔医療の利用の増加、メンタルヘルス診断におけるAIの統合、栄養補助食品と食事介入の役割の増大、雇用主がスポンサーとなるメンタルヘルス・プログラムの拡大などがあります。

妊娠中のメンタルヘルス問題に対する意識の高まりは、産後うつ病治療市場の成長を促進すると予想されます。妊娠中のメンタルヘルス問題には、妊娠中の女性に影響を及ぼすさまざまな感情的、心理的、精神的状態が含まれます。これらの問題は、ストレスやホルモンの変化によって高まることが多く、情緒的な脆弱性を増大させ、女性が妊娠中の身体的、社会的、心理的な要求を管理することをより困難にします。産後うつ病治療は、悲しみ、不安、疲労などの症状を和らげ、感情的な回復力を高め、より健全な母子の絆を育むのに役立ちます。例えば、2024年10月、米国を拠点に妊産婦のメンタルヘルス改善に取り組む非営利団体であるMaternal Mental Health Leadership Alliance(MMHLA)は、妊産婦のメンタルヘルスの状態は最も一般的な妊娠合併症であり、米国では年間80万家族が影響を受けていると報告しました。驚くべきことに、これらのケースの75%が未治療であり、母親、赤ちゃん、家族に長期的なリスクをもたらしています。このような意識の高まりが、産後うつ病治療市場の主な促進要因となっています。

産後うつ病治療市場の企業は、特に処方箋デジタル産後うつ病治療など、複数の治療法の統合を通じて、診断と治療において大きな進歩を遂げています。処方デジタル治療薬(DTx)は臨床的に検証されたモバイルベースの治療薬で、ヘルスケアプロバイダーが産後うつ病(PPD)の管理・治療のために処方します。例えば、2024年4月、米国のデジタルヘルス企業であるキュリオ・デジタル・セラピューティクス社は、産後うつ病の最初の処方箋デジタル治療薬であるママリフト・プラスのFDA認可を発表しました。この8週間のプログラムでは、医療従事者の監視のもと、認知行動療法(CBT)、行動活性化療法(BAT)、対人関係療法(IPT)、弁証法的行動療法(DBT)がモバイル機器を介して行われます。重要な研究では、ママリフト・プラス使用者のエジンバラ産後うつ病尺度(EPDS)スコアの臨床的に意味のある改善率が、対照群と比較して有意に高いことが示されました。今回のFDA認可は、軽度から中等度のPPDを治療するための非薬物的選択肢を女性に提供するものであり、より身近なものとなりました。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界産後うつ病治療PESTEL分析(政治、社会、技術、環境、法的要因、促進要因と抑制要因)
  • 最終用途産業の分析
  • 世界の産後うつ病治療市場:成長率分析
  • 世界の産後うつ病治療市場の実績:規模と成長, 2019-2024
  • 世界の産後うつ病治療市場の予測:規模と成長, 2024-2029, 2034F
  • 世界産後うつ病治療総アドレス可能市場(TAM)

第6章 市場セグメンテーション

  • 世界の産後うつ病治療市場:タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 産後不安
  • 産後ブルース
  • 産後心的外傷後ストレス障害(PTSD)
  • 産後強迫性障害(OCD)
  • 産後パニック障害
  • 産後精神病
  • 世界の産後うつ病治療市場治療の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 抗うつ薬
  • ホルモン療法
  • 心理療法
  • その他の治療の種類
  • 世界の産後うつ病治療市場患者の人口統計別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 青少年
  • 大人
  • 世界の産後うつ病治療市場:流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 病院薬局
  • 小売薬局
  • オンライン薬局
  • 世界の産後うつ病治療市場産後不安のタイプ別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 認知行動療法(CBT)
  • 抗うつ薬
  • ホルモン療法
  • サポートグループとカウンセリング
  • 世界の産後うつ病治療市場産後うつ病の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 心理療法
  • 支持療法
  • 短期投薬
  • 世界の産後うつ病治療市場産後心的外傷後ストレス障害(PTSD)の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • トラウマに焦点を当てた認知行動療法(TF-CBT)
  • 眼球運動による脱感作および再処理法(EMDR)
  • ピアサポートグループ
  • 世界の産後うつ病治療市場産後強迫性障害(OCD)の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 曝露と反応防止(ERP)
  • 抗うつ薬(SSRI)
  • 認知行動療法(CBT)
  • 支持療法
  • 世界の産後うつ病治療市場産後パニック障害の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 認知行動療法(CBT)
  • 抗うつ薬と抗不安薬
  • リラクゼーションテクニック
  • 心理療法
  • 世界の産後うつ病治療市場産後精神病の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 抗精神病薬
  • 気分安定剤
  • 電気けいれん療法(ECT)

第7章 地域別・国別分析

  • 世界の産後うつ病治療市場:地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界の産後うつ病治療市場:国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 産後うつ病治療市場:競合情勢
  • 産後うつ病治療市場:企業プロファイル
    • Biogen Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Inspira Health Network Overview, Products and Services, Strategy and Financial Analysis
    • LifeStance Health Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Max Healthcare Institute Limited Overview, Products and Services, Strategy and Financial Analysis
    • American Well Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • Sakra Premium Hospital Private Limited
  • Talkspace Inc.
  • Mental Health America
  • 31.5. Marinus Pharmaceuticals Inc.
  • 31.6. Brii Biosciences Limited
  • 31.7. Beyond Blue Ltd
  • 31.8. Blooming Wellness Center
  • 31.9. Sage Therapeutics Inc.
  • 31.10. NURX Inc.
  • 31.11. Curio Digital Therapeutics Inc.
  • 31.12. Genesis Lifestyle Medicine
  • 31.13. Postpartum Society of Florida
  • 31.14. TalktoAngel
  • 31.15. The Motherhood Center

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • 産後うつ病治療市場2029:新たな機会を提供する国
  • 産後うつ病治療市場2029:新たな機会を提供するセグメント
  • 産後うつ病治療市場2029:成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r34931

Postpartum depression (PPD) treatment refers to the medical and psychological care provided to individuals experiencing depression after childbirth. It typically involves a combination of therapy, medication, and support strategies aimed at alleviating symptoms such as persistent sadness, anxiety, fatigue, and difficulty bonding with the baby. Treatment options include medications, psychotherapy, hormonal therapy, and lifestyle interventions designed to improve maternal mental health and overall well-being.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The main types of postpartum depression treatment include postpartum anxiety, postpartum blues, postpartum post-traumatic stress disorder (PTSD), postpartum obsessive-compulsive disorder (OCD), postpartum panic disorder, and postpartum psychosis. Postpartum anxiety is a condition in which new mothers experience excessive worry, fear, or nervousness after childbirth. Treatment options such as antidepressants, hormone therapy, psychotherapy, and other interventions are available for various demographics, including adolescents and adults. These treatments are distributed through various sales channels, including hospital pharmacies, retail pharmacies, and online pharmacies.

The postpartum depression treatment market research report is one of a series of new reports from The Business Research Company that provides postpartum depression treatment market statistics, including postpartum depression treatment industry global market size, regional shares, competitors with a postpartum depression treatment market share, detailed postpartum depression treatment market segments, market trends and opportunities, and any further data you may need to thrive in the postpartum depression treatment industry. This postpartum depression treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The postpartum depression treatment market size has grown strongly in recent years. It will grow from $1.19 billion in 2024 to $1.28 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth during the historic period can be attributed to increasing awareness of maternal mental health, the growing prevalence of postpartum depression, advancements in antidepressant medications, rising acceptance of psychotherapy, and government initiatives supporting maternal mental health.

The postpartum depression treatment market size is expected to see strong growth in the next few years. It will grow to $1.70 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth during the forecast period can be attributed to the development of novel fast-acting treatments, the increasing adoption of digital mental health solutions, expanding insurance coverage for mental health services, rising demand for personalized treatment approaches, and a growing focus on hormonal therapies. Key trends expected in the forecast period include the emergence of neurosteroid-based therapies, the increasing use of telemedicine for postpartum care, the integration of AI in mental health diagnostics, the growing role of nutraceuticals and dietary interventions, and the expansion of employer-sponsored mental health programs.

The growing awareness of mental health issues during pregnancy is expected to drive the growth of the postpartum depression treatment market. Mental health issues during pregnancy encompass a range of emotional, psychological, and psychiatric conditions that affect women while they are pregnant. These issues are often heightened due to stress and hormonal changes, which can increase emotional vulnerability and make it more challenging for women to manage the physical, social, and psychological demands of pregnancy. Postpartum depression treatment helps alleviate symptoms such as sadness, anxiety, and fatigue, enhancing emotional resilience and fostering healthier mother-child bonding. For example, in October 2024, the Maternal Mental Health Leadership Alliance (MMHLA), a US-based nonprofit dedicated to improving maternal mental health, reported that maternal mental health conditions are the most common pregnancy complication, affecting 800,000 U.S. families annually. Alarmingly, 75% of these cases go untreated, posing long-term risks to mothers, babies, and families. This growing awareness is a major driver of the postpartum depression treatment market.

Companies in the postpartum depression treatment market are making significant advancements in diagnosis and treatment, particularly through the integration of multiple therapeutic modalities, such as prescription digital postpartum depression treatments. Prescription digital therapeutics (DTx) are clinically validated, mobile-based treatments that healthcare providers prescribe to manage and treat postpartum depression (PPD). For example, in April 2024, Curio Digital Therapeutics Inc., a US-based digital health company, announced FDA clearance for MamaLift Plus, the first prescription digital therapeutic for postpartum depression. This eight-week program delivers cognitive behavioral therapy (CBT), behavioral activation therapy (BAT), interpersonal therapy (IPT), and dialectical behavior therapy (DBT) via mobile devices under healthcare provider supervision. A pivotal study showed significantly higher rates of clinically meaningful improvement in Edinburgh Postnatal Depression Scale (EPDS) scores for MamaLift Plus users compared to a control group. This FDA clearance offers women a non-pharmaceutical option for treating mild to moderate PPD, making it more accessible.

In December 2022, Biogen Inc., a US-based company focusing on neurology therapies, partnered with Sage Therapeutics Inc. to develop treatments for major depressive disorder (MDD) and postpartum depression (PPD). This collaboration allows the companies to work together on medications for PPD, MDD, various mental health conditions, and neurological disorders such as essential tremors. Sage Therapeutics is a US-based company specializing in treatments for neurological conditions, including postpartum depression.

Major players in the postpartum depression treatment market are Biogen Inc., Inspira Health Network, LifeStance Health Inc., Max Healthcare Institute Limited, American Well Corporation, Sakra Premium Hospital Private Limited, Talkspace Inc., Mental Health America, 7 Cups Inc., Marinus Pharmaceuticals Inc., Brii Biosciences Limited, Beyond Blue Ltd, Blooming Wellness Center, Sage Therapeutics Inc., NURX Inc., Curio Digital Therapeutics Inc., Genesis Lifestyle Medicine, Postpartum Society of Florida, TalktoAngel, The Motherhood Center.

North America was the largest region in the postpartum depression treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in postpartum depression treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the postpartum depression treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The postpartum depression treatment market consists of revenues earned by entities by providing services such as psychotherapy, medication management, counseling, digital mental health solutions, and alternative therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. The postpartum depression treatment market also includes sales of antidepressant medications, hormone-based therapies, digital health platforms, telehealth services, wearable devices, and mobile applications that support mental health management. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Postpartum Depression Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on postpartum depression treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for postpartum depression treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The postpartum depression treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Postpartum Anxiety; Postpartum Blues; Postpartum Post-Traumatic Stress Disorder (PTSD); Postpartum Obsessive-Compulsive Disorder (OCD); Postpartum Panic Disorder; Postpartum Psychosis
  • 2) By Treatment Type: Antidepressants; Hormone Therapy; Psychotherapy; Other Treatment Types
  • 3) By Patient Demographics: Adolescents; Adults
  • 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
  • Subsegments:
  • 1) By Postpartum Anxiety: Cognitive Behavioral Therapy (CBT); Antidepressant Medications; Hormonal Therapy; Support Groups And Counseling
  • 2) By Postpartum Blues: Psychotherapy; Supportive Care; Short-Term Medication
  • 3) By Postpartum Post-Traumatic Stress Disorder (PTSD): Trauma-Focused Cognitive Behavioral Therapy (TF-CBT); Eye Movement Desensitization And Reprocessing (EMDR); Medication; Peer Support Groups
  • 4) By Postpartum Obsessive-Compulsive Disorder (OCD): Exposure And Response Prevention (ERP); Antidepressant Medications (SSRIs); Cognitive Behavioral Therapy (CBT); Supportive Therapy
  • 5) By Postpartum Panic Disorder: Cognitive Behavioral Therapy (CBT); Antidepressants And Anti-Anxiety Medications; Relaxation Techniques; Psychotherapy
  • 6) By Postpartum Psychosis: Antipsychotic Medications; Mood Stabilizers; Electroconvulsive Therapy (ECT)
  • Companies Mentioned: Biogen Inc.; Inspira Health Network; LifeStance Health Inc.; Max Healthcare Institute Limited; American Well Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Postpartum Depression Treatment Market Characteristics

3. Postpartum Depression Treatment Market Trends And Strategies

4. Postpartum Depression Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Postpartum Depression Treatment Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Postpartum Depression Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Postpartum Depression Treatment Market Growth Rate Analysis
  • 5.4. Global Postpartum Depression Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Postpartum Depression Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Postpartum Depression Treatment Total Addressable Market (TAM)

6. Postpartum Depression Treatment Market Segmentation

  • 6.1. Global Postpartum Depression Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Postpartum Anxiety
  • Postpartum Blues
  • Postpartum Post-Traumatic Stress Disorder (PTSD)
  • Postpartum Obsessive-Compulsive Disorder (OCD)
  • Postpartum Panic Disorder
  • Postpartum Psychosis
  • 6.2. Global Postpartum Depression Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Antidepressants
  • Hormone Therapy
  • Psychotherapy
  • Other Treatment Types
  • 6.3. Global Postpartum Depression Treatment Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Adolescents
  • Adults
  • 6.4. Global Postpartum Depression Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • 6.5. Global Postpartum Depression Treatment Market, Sub-Segmentation Of Postpartum Anxiety, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cognitive Behavioral Therapy (CBT)
  • Antidepressant Medications
  • Hormonal Therapy
  • Support Groups And Counseling
  • 6.6. Global Postpartum Depression Treatment Market, Sub-Segmentation Of Postpartum Blues, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Psychotherapy
  • Supportive Care
  • Short-term Medication
  • 6.7. Global Postpartum Depression Treatment Market, Sub-Segmentation Of Postpartum Post-Traumatic Stress Disorder (PTSD), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Trauma-Focused Cognitive Behavioral Therapy (TF-CBT)
  • Eye Movement Desensitization and Reprocessing (EMDR)
  • Medication
  • Peer Support Groups
  • 6.8. Global Postpartum Depression Treatment Market, Sub-Segmentation Of Postpartum Obsessive-Compulsive Disorder (OCD), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Exposure and Response Prevention (ERP)
  • Antidepressant Medications (SSRIs)
  • Cognitive Behavioral Therapy (CBT)
  • Supportive Therapy
  • 6.9. Global Postpartum Depression Treatment Market, Sub-Segmentation Of Postpartum Panic Disorder, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cognitive Behavioral Therapy (CBT)
  • Antidepressants And Anti-Anxiety Medications
  • Relaxation Techniques
  • Psychotherapy
  • 6.10. Global Postpartum Depression Treatment Market, Sub-Segmentation Of Postpartum Psychosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Antipsychotic Medications
  • Mood Stabilizers
  • Electroconvulsive Therapy (ECT)

7. Postpartum Depression Treatment Market Regional And Country Analysis

  • 7.1. Global Postpartum Depression Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Postpartum Depression Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Postpartum Depression Treatment Market

  • 8.1. Asia-Pacific Postpartum Depression Treatment Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Postpartum Depression Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Postpartum Depression Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Postpartum Depression Treatment Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Postpartum Depression Treatment Market

  • 9.1. China Postpartum Depression Treatment Market Overview
  • 9.2. China Postpartum Depression Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Postpartum Depression Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Postpartum Depression Treatment Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Postpartum Depression Treatment Market

  • 10.1. India Postpartum Depression Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Postpartum Depression Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Postpartum Depression Treatment Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Postpartum Depression Treatment Market

  • 11.1. Japan Postpartum Depression Treatment Market Overview
  • 11.2. Japan Postpartum Depression Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Postpartum Depression Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Postpartum Depression Treatment Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Postpartum Depression Treatment Market

  • 12.1. Australia Postpartum Depression Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Postpartum Depression Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Postpartum Depression Treatment Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Postpartum Depression Treatment Market

  • 13.1. Indonesia Postpartum Depression Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Postpartum Depression Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Postpartum Depression Treatment Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Postpartum Depression Treatment Market

  • 14.1. South Korea Postpartum Depression Treatment Market Overview
  • 14.2. South Korea Postpartum Depression Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Postpartum Depression Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Postpartum Depression Treatment Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Postpartum Depression Treatment Market

  • 15.1. Western Europe Postpartum Depression Treatment Market Overview
  • 15.2. Western Europe Postpartum Depression Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Postpartum Depression Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Postpartum Depression Treatment Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Postpartum Depression Treatment Market

  • 16.1. UK Postpartum Depression Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Postpartum Depression Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Postpartum Depression Treatment Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Postpartum Depression Treatment Market

  • 17.1. Germany Postpartum Depression Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Postpartum Depression Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Postpartum Depression Treatment Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Postpartum Depression Treatment Market

  • 18.1. France Postpartum Depression Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Postpartum Depression Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Postpartum Depression Treatment Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Postpartum Depression Treatment Market

  • 19.1. Italy Postpartum Depression Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Postpartum Depression Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Postpartum Depression Treatment Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Postpartum Depression Treatment Market

  • 20.1. Spain Postpartum Depression Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Postpartum Depression Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Postpartum Depression Treatment Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Postpartum Depression Treatment Market

  • 21.1. Eastern Europe Postpartum Depression Treatment Market Overview
  • 21.2. Eastern Europe Postpartum Depression Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Postpartum Depression Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Postpartum Depression Treatment Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Postpartum Depression Treatment Market

  • 22.1. Russia Postpartum Depression Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Postpartum Depression Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Postpartum Depression Treatment Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Postpartum Depression Treatment Market

  • 23.1. North America Postpartum Depression Treatment Market Overview
  • 23.2. North America Postpartum Depression Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Postpartum Depression Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Postpartum Depression Treatment Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Postpartum Depression Treatment Market

  • 24.1. USA Postpartum Depression Treatment Market Overview
  • 24.2. USA Postpartum Depression Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Postpartum Depression Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Postpartum Depression Treatment Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Postpartum Depression Treatment Market

  • 25.1. Canada Postpartum Depression Treatment Market Overview
  • 25.2. Canada Postpartum Depression Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Postpartum Depression Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Postpartum Depression Treatment Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Postpartum Depression Treatment Market

  • 26.1. South America Postpartum Depression Treatment Market Overview
  • 26.2. South America Postpartum Depression Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Postpartum Depression Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Postpartum Depression Treatment Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Postpartum Depression Treatment Market

  • 27.1. Brazil Postpartum Depression Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Postpartum Depression Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Postpartum Depression Treatment Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Postpartum Depression Treatment Market

  • 28.1. Middle East Postpartum Depression Treatment Market Overview
  • 28.2. Middle East Postpartum Depression Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Postpartum Depression Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Postpartum Depression Treatment Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Postpartum Depression Treatment Market

  • 29.1. Africa Postpartum Depression Treatment Market Overview
  • 29.2. Africa Postpartum Depression Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Postpartum Depression Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Postpartum Depression Treatment Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Postpartum Depression Treatment Market Competitive Landscape And Company Profiles

  • 30.1. Postpartum Depression Treatment Market Competitive Landscape
  • 30.2. Postpartum Depression Treatment Market Company Profiles
    • 30.2.1. Biogen Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Inspira Health Network Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. LifeStance Health Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Max Healthcare Institute Limited Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. American Well Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Postpartum Depression Treatment Market Other Major And Innovative Companies

  • 31.1. Sakra Premium Hospital Private Limited
  • 31.2. Talkspace Inc.
  • 31.3. Mental Health America
    • 31.4. 7 Cups Inc.
  • 31.5. Marinus Pharmaceuticals Inc.
  • 31.6. Brii Biosciences Limited
  • 31.7. Beyond Blue Ltd
  • 31.8. Blooming Wellness Center
  • 31.9. Sage Therapeutics Inc.
  • 31.10. NURX Inc.
  • 31.11. Curio Digital Therapeutics Inc.
  • 31.12. Genesis Lifestyle Medicine
  • 31.13. Postpartum Society of Florida
  • 31.14. TalktoAngel
  • 31.15. The Motherhood Center

32. Global Postpartum Depression Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Postpartum Depression Treatment Market

34. Recent Developments In The Postpartum Depression Treatment Market

35. Postpartum Depression Treatment Market High Potential Countries, Segments and Strategies

  • 35.1 Postpartum Depression Treatment Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Postpartum Depression Treatment Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Postpartum Depression Treatment Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
  • 250617_r34931_Postpartum_Depression_Treatment_GMR_2025